Faeth Therapeutics, Inc. Interest Expense
Faeth Therapeutics, Inc. (FTH) reported Interest Expense of $32.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-03-30
- Faeth Therapeutics, Inc. interest expense for the quarter ending 2025-12-31 was $3.00K, a 82.35% decline year-over-year.
- Faeth Therapeutics, Inc. interest expense for the quarter ending 2025-09-30 was $6.00K, a 71.43% decline year-over-year.
- Faeth Therapeutics, Inc. interest expense for the quarter ending 2025-06-30 was $10.00K, a 58.33% decline year-over-year.
- Faeth Therapeutics, Inc. interest expense for the quarter ending 2025-03-31 was $13.00K, a 53.57% decline year-over-year.
- Faeth Therapeutics, Inc. interest expense for fiscal 2025 was $32.00K, a 64.44% decline from fiscal 2024.
- Faeth Therapeutics, Inc. interest expense for fiscal 2024 was $90.00K, a 37.50% decline from fiscal 2023.
- Faeth Therapeutics, Inc. interest expense for fiscal 2023 was $144.00K, a 34.25% decline from fiscal 2022.
- Faeth Therapeutics, Inc. interest expense for fiscal 2022 was $219.00K, a 67.31% decline from fiscal 2021.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $9.00K derived: sum of 2 quarters · filed 2026-03-30 | $19.00K derived: sum of 3 quarters · filed 2026-03-30 | $32.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $6.00K 10-Q · filed 2025-11-14 | $16.00K derived: sum of 2 quarters · filed 2025-11-14 | $29.00K 10-Q · filed 2025-11-14 | $46.00K derived: sum of 4 quarters · filed 2026-03-30 |
| 2025-06-30 | $10.00K 10-Q · filed 2025-08-05 | $23.00K 10-Q · filed 2025-08-05 | $40.00K derived: sum of 3 quarters · filed 2026-03-30 | $61.00K derived: sum of 4 quarters · filed 2026-03-30 |
| 2025-03-31 | $13.00K 10-Q · filed 2025-05-06 | $30.00K derived: sum of 2 quarters · filed 2026-03-30 | $51.00K derived: sum of 3 quarters · filed 2026-03-30 | $75.00K derived: sum of 4 quarters · filed 2026-03-30 |
| 2024-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $38.00K derived: sum of 2 quarters · filed 2026-03-30 | $62.00K derived: sum of 3 quarters · filed 2026-03-30 | $90.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $21.00K 10-Q · filed 2025-11-14 | $45.00K derived: sum of 2 quarters · filed 2025-11-14 | $73.00K 10-Q · filed 2025-11-14 | $104.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $24.00K 10-Q · filed 2025-08-05 | $52.00K 10-Q · filed 2025-08-05 | $83.00K derived: sum of 3 quarters · filed 2025-08-05 | $116.00K derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $28.00K 10-Q · filed 2025-05-06 | $59.00K derived: sum of 2 quarters · filed 2025-05-06 | $92.00K derived: sum of 3 quarters · filed 2025-05-06 | $130.00K derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $64.00K derived: sum of 2 quarters · filed 2025-03-28 | $102.00K derived: sum of 3 quarters · filed 2025-03-28 | $144.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | $33.00K 10-Q · filed 2024-11-14 | $71.00K derived: sum of 2 quarters · filed 2024-11-14 | $113.00K 10-Q · filed 2024-11-14 | -$93.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $38.00K 10-Q · filed 2024-08-06 | $80.00K 10-Q · filed 2024-08-06 | -$126.00K derived: sum of 3 quarters · filed 2024-08-06 | -$116.00K derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $42.00K 10-Q · filed 2024-05-09 | -$164.00K derived: sum of 2 quarters · filed 2024-05-09 | -$154.00K derived: sum of 3 quarters · filed 2024-05-09 | $18.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$206.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$196.00K derived: sum of 2 quarters · filed 2024-02-29 | -$24.00K derived: sum of 3 quarters · filed 2024-02-29 | $219.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | $10.00K 10-Q · filed 2023-11-07 | $182.00K derived: sum of 2 quarters · filed 2023-11-07 | $425.00K 10-Q · filed 2023-11-07 | $731.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $172.00K 10-Q · filed 2023-08-03 | $415.00K 10-Q · filed 2023-08-03 | $721.00K derived: sum of 3 quarters · filed 2023-08-03 | $935.00K derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $243.00K 10-Q · filed 2023-05-09 | $549.00K derived: sum of 2 quarters · filed 2023-05-09 | $763.00K derived: sum of 3 quarters · filed 2023-05-09 | $910.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $306.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $520.00K derived: sum of 2 quarters · filed 2023-03-29 | $667.00K derived: sum of 3 quarters · filed 2023-03-29 | $670.00K 10-K · filed 2023-03-29 |
| 2021-09-30 | $214.00K 10-Q · filed 2022-11-08 | $361.00K derived: sum of 2 quarters · filed 2022-11-08 | $364.00K 10-Q · filed 2022-11-08 | $418.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $147.00K 10-Q · filed 2022-08-09 | $150.00K 10-Q · filed 2022-08-09 | $204.00K derived: sum of 3 quarters · filed 2022-08-09 | $207.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $3.00K 10-Q · filed 2022-05-10 | $57.00K derived: sum of 2 quarters · filed 2022-05-10 | $60.00K derived: sum of 3 quarters · filed 2022-05-10 | $63.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $57.00K derived: sum of 2 quarters · filed 2022-03-15 | $60.00K derived: sum of 3 quarters · filed 2022-03-15 | $1.69M 10-K · filed 2022-03-15 |
| 2020-09-30 | $3.00K 10-Q · filed 2021-11-10 | $6.00K derived: sum of 2 quarters · filed 2021-11-10 | $1.64M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $3.00K 10-Q · filed 2021-08-11 | $1.63M 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | $1.63M 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |